Back to top

CYTK Maintained by RBC Capital -- Price Target Lowered to $117

CYTK Maintained by RBC Capital -- Price Target Lowered to $117

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Cytokinetics, Incorporated (CYTK)